Skip to content Tesamorelin (Egrifta®) is an FDA-approved GHRH analogue. At Remedy in Maple Grove, MN, a licensed provider evaluates whether it’s appropriate for you and is transparent about the
difference between its approved use and any off-label consideration.
Tesamorelin is a GHRH analogue that is FDA-approved to reduce excess visceral abdominal fat in adults with HIV-associated lipodystrophy. Any use outside that approved indication is off-label and is a clinical decision your provider makes and explains during your evaluation. Whether it’s appropriate for you depends on your labs and history.
Grounded in your bloodwork.
Your provider explains exactly how it would be used in your case.
Follow-up is part of care.
Benefits, risks, and evidence discussed openly.
Prescribed only within a provider-patient relationship.
Sourced appropriately and handled under medical supervision.
After labs and a consultation, your provider determines whether tesamorelin is appropriate and whether that would be its approved indication or an off-label use they judge suitable. They explain the plan, obtain consent, and monitor your response at follow-ups.
Bloodwork is completed first, followed by a consultation to review your results, history, and goals.
Eligibility and approved-vs-off-label use discussed.
If appropriate, prescribed with clear guidance.
Monitoring over time.
Are an adult seeking medically supervised, lab-based care.
Want a provider who is transparent about approved vs. off-label use.
Prefer clinical oversight and proper sourcing.
Are in general health with realistic expectations.
Eligibility is determined by your provider.
Tesamorelin is prescribed only pursuant to a valid prescription after a legitimate provider-patient relationship. Where use would be off-label, your provider explains that clearly. We don’t promise specific results or sell it as a retail product.
At Remedy Medical Aesthetics & Wellness in Maple Grove, MN, we provide more than a prescription; we provide clarity and clinical oversight. Patients choose us because:
Recommendations are grounded in your bloodwork and clinical history, not assumptions about who might benefit.
Your provider explains exactly how tesamorelin would be used in your case, including whether it falls within its FDA-approved indication or is an off-label use.
Tesamorelin is prescribed only within a provider-patient relationship, with monitoring built into your plan.
Benefits, risks, and the current evidence are discussed openly before you decide whether tesamorelin is right for you.
It’s FDA-approved to reduce excess visceral abdominal fat in adults with HIV-associated lipodystrophy. Other uses are off-label and provider-determined.
That would be off-label. Whether it’s appropriate for you is a decision your provider makes and explains – we can’t determine it on a webpage.
Yes, always, after an evaluation.
